Several global buyout funds, including Blackstone, Baring PE Asia, EQT, Warburg Pincus, Bain Capital, and KKR, have expressed their interest in acquiring the majority stake in Indira IVF, India's largest chain of fertility clinics. The deal is expected to be valued at around $1bn, and a formal sale process has been launched by investment banks Goldman Sachs and JPMorgan. Indira IVF has 114 centres across the country, and performed about 40,000 IVF procedures in 2022. The Indian fertility industry is expected to reach $3bn by 2030, with IVF cycles costing between INR1.5-2 lakhs ($2,000-$2,700) each.
